CXCR3, which is present on activated MO/MAs and on activated T cells,[52] binds several rIFN-γ1b- induceable chemokines, including CXCL9/Mig, CXCL10/IP-10, and CXCL11/I-TAC[53] These chemokines might facilitate recruitment of activated leukocyte subsets to the tumor site. The gene discussed is CXCL9; the disease is neoplasm.